Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: George T. Santamaria who wrote (3333)	12/16/1997 1:38:00 AM
From: JOHN W.	Respond to of 6136

No argument there, but the stock was trading down severely for days prior to the announcement and there also seems to be some company insiders selling large positions when the stock was still in the 50s. Could todays action be a redistribution of tech money looking for beat up-oversold stocks whose earnings are impervious to Asia over the next year? I don't think of AGPH as a defensive move or a "flight to safety" and other biotechs really didn't move today. Could be a fluke, interesting day tommorrow.